Alzheimer Disease

Citations 51-60 of 139 total displayed.

Past content (since Mar 1998):

Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply

Catherine D. DeAngelis; Phil B. Fontanarosa
JAMA 2008; 300: 905-906. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Researchers Identify Neurological Risks

Bridget M. Kuehn
JAMA 2008; 299: 2375-2376. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Guideline: Dementia Drugs’ Benefits Uncertain

Rebecca Voelker
JAMA 2008; 299: 1763. [Extract] [Full text] [PDF]  

Special Communications
Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents From Rofecoxib Litigation

Joseph S. Ross; Kevin P. Hill; David S. Egilman; Harlan M. Krumholz
JAMA 2008; 299: 1800-1812. [Abstract] [Full text] [PDF]  

Special Communications
Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Cognitive Impairment: A Case Study Based on Documents From Rofecoxib Litigation

Bruce M. Psaty; Richard A. Kronmal
JAMA 2008; 299: 1813-1817. [Abstract] [Full text] [PDF] [ JAMA Report Video ]  

Lab Reports
Alzheimer Plaques

Tracy Hampton
JAMA 2008; 299: 1533-a. [Extract] [Full text] [PDF]  

Clinical Crossroads
A 74-Year-Old Man With Memory Loss and Neuropathy Who Enjoys Alcoholic Beverages

John C. M. Brust
JAMA 2008; 299: 1046-1054. [Abstract] [Full text] [PDF] [ Video ]  

Lab Reports
Alzheimer Disease Trigger

Tracy Hampton
JAMA 2008; 299: 513. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Researchers Report New Clues to Dementia

M. J. Friedrich
JAMA 2007; 298: 161-163. [Extract] [Full text] [PDF]  

JAMA Patient Page
Dementia

Janet M. Torpy; Cassio Lynm; Richard M. Glass
JAMA 2007; 297: 2436. [Extract] [Full text] [PDF] [ Spanish PDF ]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14